General Information of the Compound
Compound ID
CP0512242
Compound Name
5-(benzylthio)thiazolo[4,5-d]pyrimidine-2,7-diamine
    Show/Hide
Structure
Formula
C12H11N5S2
Molecular Weight
289.389
Canonical SMILES
Nc1nc2nc(SCc3ccccc3)nc(N)c2s1
    Show/Hide
InChI
InChI=1S/C12H11N5S2/c13-9-8-10(16-11(14)19-8)17-12(15-9)18-6-7-4-2-1-3-5-7/h1-5H,6H2,(H4,13,14,15,16,17)
    Show/Hide
InChIKey
FDNXRODGTKLOEH-UHFFFAOYSA-N
Physicochemical Property
logP
2.543
Rotatable Bonds
3
Heavy Atom Count
19
Polar Areas
90.71
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44407558
ChEMBL ID
CHEMBL201800
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01013, C-X-C chemokine receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS